Global Nasal Spray Flu Vaccines Market Growth 2025-2031

December 2025 | 105 pages | ID: G062E36C8476EN
LP Information

Abstracts

The global Nasal Spray Flu Vaccines market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the “Nasal Spray Flu Vaccines Industry Forecast” looks at past sales and reviews total world Nasal Spray Flu Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Nasal Spray Flu Vaccines sales for 2025 through 2031. With Nasal Spray Flu Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nasal Spray Flu Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Nasal Spray Flu Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nasal Spray Flu Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nasal Spray Flu Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nasal Spray Flu Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nasal Spray Flu Vaccines.

This report presents a comprehensive overview, market shares, and growth opportunities of Nasal Spray Flu Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Trivalent Flu Vaccine
• Quadrivalent Flu Vaccine

Segmentation by Application:

• Hospital
• Clinic
• Public Health Agency
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Sanofi Pasteur
• AstraZeneca
• CSL
• Abbott
• GlaxoSmithKline
• Serum Institute of India

Key Questions Addressed in this Report

What is the 10-year outlook for the global Nasal Spray Flu Vaccines market?

What factors are driving Nasal Spray Flu Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Nasal Spray Flu Vaccines market opportunities vary by end market size?

How does Nasal Spray Flu Vaccines break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Nasal Spray Flu Vaccines Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Nasal Spray Flu Vaccines by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Nasal Spray Flu Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Nasal Spray Flu Vaccines Segment by Type
  2.2.1 Trivalent Flu Vaccine
  2.2.2 Quadrivalent Flu Vaccine
2.3 Nasal Spray Flu Vaccines Sales by Type
  2.3.1 Global Nasal Spray Flu Vaccines Sales Market Share by Type (2020-2025)
  2.3.2 Global Nasal Spray Flu Vaccines Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Nasal Spray Flu Vaccines Sale Price by Type (2020-2025)
2.4 Nasal Spray Flu Vaccines Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Public Health Agency
  2.4.4 Other
2.5 Nasal Spray Flu Vaccines Sales by Application
  2.5.1 Global Nasal Spray Flu Vaccines Sale Market Share by Application (2020-2025)
  2.5.2 Global Nasal Spray Flu Vaccines Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Nasal Spray Flu Vaccines Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Nasal Spray Flu Vaccines Breakdown Data by Company
  3.1.1 Global Nasal Spray Flu Vaccines Annual Sales by Company (2020-2025)
  3.1.2 Global Nasal Spray Flu Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Nasal Spray Flu Vaccines Annual Revenue by Company (2020-2025)
  3.2.1 Global Nasal Spray Flu Vaccines Revenue by Company (2020-2025)
  3.2.2 Global Nasal Spray Flu Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Nasal Spray Flu Vaccines Sale Price by Company
3.4 Key Manufacturers Nasal Spray Flu Vaccines Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Nasal Spray Flu Vaccines Product Location Distribution
  3.4.2 Players Nasal Spray Flu Vaccines Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR NASAL SPRAY FLU VACCINES BY GEOGRAPHIC REGION

4.1 World Historic Nasal Spray Flu Vaccines Market Size by Geographic Region (2020-2025)
  4.1.1 Global Nasal Spray Flu Vaccines Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Nasal Spray Flu Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Nasal Spray Flu Vaccines Market Size by Country/Region (2020-2025)
  4.2.1 Global Nasal Spray Flu Vaccines Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Nasal Spray Flu Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nasal Spray Flu Vaccines Sales Growth
4.4 APAC Nasal Spray Flu Vaccines Sales Growth
4.5 Europe Nasal Spray Flu Vaccines Sales Growth
4.6 Middle East & Africa Nasal Spray Flu Vaccines Sales Growth

5 AMERICAS

5.1 Americas Nasal Spray Flu Vaccines Sales by Country
  5.1.1 Americas Nasal Spray Flu Vaccines Sales by Country (2020-2025)
  5.1.2 Americas Nasal Spray Flu Vaccines Revenue by Country (2020-2025)
5.2 Americas Nasal Spray Flu Vaccines Sales by Type (2020-2025)
5.3 Americas Nasal Spray Flu Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Nasal Spray Flu Vaccines Sales by Region
  6.1.1 APAC Nasal Spray Flu Vaccines Sales by Region (2020-2025)
  6.1.2 APAC Nasal Spray Flu Vaccines Revenue by Region (2020-2025)
6.2 APAC Nasal Spray Flu Vaccines Sales by Type (2020-2025)
6.3 APAC Nasal Spray Flu Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Nasal Spray Flu Vaccines by Country
  7.1.1 Europe Nasal Spray Flu Vaccines Sales by Country (2020-2025)
  7.1.2 Europe Nasal Spray Flu Vaccines Revenue by Country (2020-2025)
7.2 Europe Nasal Spray Flu Vaccines Sales by Type (2020-2025)
7.3 Europe Nasal Spray Flu Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Nasal Spray Flu Vaccines by Country
  8.1.1 Middle East & Africa Nasal Spray Flu Vaccines Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Nasal Spray Flu Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Nasal Spray Flu Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Nasal Spray Flu Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nasal Spray Flu Vaccines
10.3 Manufacturing Process Analysis of Nasal Spray Flu Vaccines
10.4 Industry Chain Structure of Nasal Spray Flu Vaccines

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Nasal Spray Flu Vaccines Distributors
11.3 Nasal Spray Flu Vaccines Customer

12 WORLD FORECAST REVIEW FOR NASAL SPRAY FLU VACCINES BY GEOGRAPHIC REGION

12.1 Global Nasal Spray Flu Vaccines Market Size Forecast by Region
  12.1.1 Global Nasal Spray Flu Vaccines Forecast by Region (2026-2031)
  12.1.2 Global Nasal Spray Flu Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Nasal Spray Flu Vaccines Forecast by Type (2026-2031)
12.7 Global Nasal Spray Flu Vaccines Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Sanofi Pasteur
  13.1.1 Sanofi Pasteur Company Information
  13.1.2 Sanofi Pasteur Nasal Spray Flu Vaccines Product Portfolios and Specifications
  13.1.3 Sanofi Pasteur Nasal Spray Flu Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Sanofi Pasteur Main Business Overview
  13.1.5 Sanofi Pasteur Latest Developments
13.2 AstraZeneca
  13.2.1 AstraZeneca Company Information
  13.2.2 AstraZeneca Nasal Spray Flu Vaccines Product Portfolios and Specifications
  13.2.3 AstraZeneca Nasal Spray Flu Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 AstraZeneca Main Business Overview
  13.2.5 AstraZeneca Latest Developments
13.3 CSL
  13.3.1 CSL Company Information
  13.3.2 CSL Nasal Spray Flu Vaccines Product Portfolios and Specifications
  13.3.3 CSL Nasal Spray Flu Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 CSL Main Business Overview
  13.3.5 CSL Latest Developments
13.4 Abbott
  13.4.1 Abbott Company Information
  13.4.2 Abbott Nasal Spray Flu Vaccines Product Portfolios and Specifications
  13.4.3 Abbott Nasal Spray Flu Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Abbott Main Business Overview
  13.4.5 Abbott Latest Developments
13.5 GlaxoSmithKline
  13.5.1 GlaxoSmithKline Company Information
  13.5.2 GlaxoSmithKline Nasal Spray Flu Vaccines Product Portfolios and Specifications
  13.5.3 GlaxoSmithKline Nasal Spray Flu Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 GlaxoSmithKline Main Business Overview
  13.5.5 GlaxoSmithKline Latest Developments
13.6 Serum Institute of India
  13.6.1 Serum Institute of India Company Information
  13.6.2 Serum Institute of India Nasal Spray Flu Vaccines Product Portfolios and Specifications
  13.6.3 Serum Institute of India Nasal Spray Flu Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Serum Institute of India Main Business Overview
  13.6.5 Serum Institute of India Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Nasal Spray Flu Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Nasal Spray Flu Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Trivalent Flu Vaccine
Table 4. Major Players of Quadrivalent Flu Vaccine
Table 5. Global Nasal Spray Flu Vaccines Sales by Type (2020-2025) & (K Doses)
Table 6. Global Nasal Spray Flu Vaccines Sales Market Share by Type (2020-2025)
Table 7. Global Nasal Spray Flu Vaccines Revenue by Type (2020-2025) & ($ million)
Table 8. Global Nasal Spray Flu Vaccines Revenue Market Share by Type (2020-2025)
Table 9. Global Nasal Spray Flu Vaccines Sale Price by Type (2020-2025) & (USD/Dose)
Table 10. Global Nasal Spray Flu Vaccines Sale by Application (2020-2025) & (K Doses)
Table 11. Global Nasal Spray Flu Vaccines Sale Market Share by Application (2020-2025)
Table 12. Global Nasal Spray Flu Vaccines Revenue by Application (2020-2025) & ($ million)
Table 13. Global Nasal Spray Flu Vaccines Revenue Market Share by Application (2020-2025)
Table 14. Global Nasal Spray Flu Vaccines Sale Price by Application (2020-2025) & (USD/Dose)
Table 15. Global Nasal Spray Flu Vaccines Sales by Company (2020-2025) & (K Doses)
Table 16. Global Nasal Spray Flu Vaccines Sales Market Share by Company (2020-2025)
Table 17. Global Nasal Spray Flu Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Nasal Spray Flu Vaccines Revenue Market Share by Company (2020-2025)
Table 19. Global Nasal Spray Flu Vaccines Sale Price by Company (2020-2025) & (USD/Dose)
Table 20. Key Manufacturers Nasal Spray Flu Vaccines Producing Area Distribution and Sales Area
Table 21. Players Nasal Spray Flu Vaccines Products Offered
Table 22. Nasal Spray Flu Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Nasal Spray Flu Vaccines Sales by Geographic Region (2020-2025) & (K Doses)
Table 26. Global Nasal Spray Flu Vaccines Sales Market Share Geographic Region (2020-2025)
Table 27. Global Nasal Spray Flu Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Nasal Spray Flu Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Nasal Spray Flu Vaccines Sales by Country/Region (2020-2025) & (K Doses)
Table 30. Global Nasal Spray Flu Vaccines Sales Market Share by Country/Region (2020-2025)
Table 31. Global Nasal Spray Flu Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Nasal Spray Flu Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Nasal Spray Flu Vaccines Sales by Country (2020-2025) & (K Doses)
Table 34. Americas Nasal Spray Flu Vaccines Sales Market Share by Country (2020-2025)
Table 35. Americas Nasal Spray Flu Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Nasal Spray Flu Vaccines Sales by Type (2020-2025) & (K Doses)
Table 37. Americas Nasal Spray Flu Vaccines Sales by Application (2020-2025) & (K Doses)
Table 38. APAC Nasal Spray Flu Vaccines Sales by Region (2020-2025) & (K Doses)
Table 39. APAC Nasal Spray Flu Vaccines Sales Market Share by Region (2020-2025)
Table 40. APAC Nasal Spray Flu Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Nasal Spray Flu Vaccines Sales by Type (2020-2025) & (K Doses)
Table 42. APAC Nasal Spray Flu Vaccines Sales by Application (2020-2025) & (K Doses)
Table 43. Europe Nasal Spray Flu Vaccines Sales by Country (2020-2025) & (K Doses)
Table 44. Europe Nasal Spray Flu Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Nasal Spray Flu Vaccines Sales by Type (2020-2025) & (K Doses)
Table 46. Europe Nasal Spray Flu Vaccines Sales by Application (2020-2025) & (K Doses)
Table 47. Middle East & Africa Nasal Spray Flu Vaccines Sales by Country (2020-2025) & (K Doses)
Table 48. Middle East & Africa Nasal Spray Flu Vaccines Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Nasal Spray Flu Vaccines Sales by Type (2020-2025) & (K Doses)
Table 50. Middle East & Africa Nasal Spray Flu Vaccines Sales by Application (2020-2025) & (K Doses)
Table 51. Key Market Drivers & Growth Opportunities of Nasal Spray Flu Vaccines
Table 52. Key Market Challenges & Risks of Nasal Spray Flu Vaccines
Table 53. Key Industry Trends of Nasal Spray Flu Vaccines
Table 54. Nasal Spray Flu Vaccines Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Nasal Spray Flu Vaccines Distributors List
Table 57. Nasal Spray Flu Vaccines Customer List
Table 58. Global Nasal Spray Flu Vaccines Sales Forecast by Region (2026-2031) & (K Doses)
Table 59. Global Nasal Spray Flu Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Nasal Spray Flu Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 61. Americas Nasal Spray Flu Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Nasal Spray Flu Vaccines Sales Forecast by Region (2026-2031) & (K Doses)
Table 63. APAC Nasal Spray Flu Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Nasal Spray Flu Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 65. Europe Nasal Spray Flu Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Nasal Spray Flu Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 67. Middle East & Africa Nasal Spray Flu Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Nasal Spray Flu Vaccines Sales Forecast by Type (2026-2031) & (K Doses)
Table 69. Global Nasal Spray Flu Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Nasal Spray Flu Vaccines Sales Forecast by Application (2026-2031) & (K Doses)
Table 71. Global Nasal Spray Flu Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Sanofi Pasteur Basic Information, Nasal Spray Flu Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Pasteur Nasal Spray Flu Vaccines Product Portfolios and Specifications
Table 74. Sanofi Pasteur Nasal Spray Flu Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 75. Sanofi Pasteur Main Business
Table 76. Sanofi Pasteur Latest Developments
Table 77. AstraZeneca Basic Information, Nasal Spray Flu Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 78. AstraZeneca Nasal Spray Flu Vaccines Product Portfolios and Specifications
Table 79. AstraZeneca Nasal Spray Flu Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. AstraZeneca Main Business
Table 81. AstraZeneca Latest Developments
Table 82. CSL Basic Information, Nasal Spray Flu Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 83. CSL Nasal Spray Flu Vaccines Product Portfolios and Specifications
Table 84. CSL Nasal Spray Flu Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 85. CSL Main Business
Table 86. CSL Latest Developments
Table 87. Abbott Basic Information, Nasal Spray Flu Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 88. Abbott Nasal Spray Flu Vaccines Product Portfolios and Specifications
Table 89. Abbott Nasal Spray Flu Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 90. Abbott Main Business
Table 91. Abbott Latest Developments
Table 92. GlaxoSmithKline Basic Information, Nasal Spray Flu Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. GlaxoSmithKline Nasal Spray Flu Vaccines Product Portfolios and Specifications
Table 94. GlaxoSmithKline Nasal Spray Flu Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 95. GlaxoSmithKline Main Business
Table 96. GlaxoSmithKline Latest Developments
Table 97. Serum Institute of India Basic Information, Nasal Spray Flu Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. Serum Institute of India Nasal Spray Flu Vaccines Product Portfolios and Specifications
Table 99. Serum Institute of India Nasal Spray Flu Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 100. Serum Institute of India Main Business
Table 101. Serum Institute of India Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Nasal Spray Flu Vaccines
Figure 2. Nasal Spray Flu Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nasal Spray Flu Vaccines Sales Growth Rate 2020-2031 (K Doses)
Figure 7. Global Nasal Spray Flu Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Nasal Spray Flu Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Nasal Spray Flu Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Nasal Spray Flu Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Trivalent Flu Vaccine
Figure 12. Product Picture of Quadrivalent Flu Vaccine
Figure 13. Global Nasal Spray Flu Vaccines Sales Market Share by Type in 2025
Figure 14. Global Nasal Spray Flu Vaccines Revenue Market Share by Type (2020-2025)
Figure 15. Nasal Spray Flu Vaccines Consumed in Hospital
Figure 16. Global Nasal Spray Flu Vaccines Market: Hospital (2020-2025) & (K Doses)
Figure 17. Nasal Spray Flu Vaccines Consumed in Clinic
Figure 18. Global Nasal Spray Flu Vaccines Market: Clinic (2020-2025) & (K Doses)
Figure 19. Nasal Spray Flu Vaccines Consumed in Public Health Agency
Figure 20. Global Nasal Spray Flu Vaccines Market: Public Health Agency (2020-2025) & (K Doses)
Figure 21. Nasal Spray Flu Vaccines Consumed in Other
Figure 22. Global Nasal Spray Flu Vaccines Market: Other (2020-2025) & (K Doses)
Figure 23. Global Nasal Spray Flu Vaccines Sale Market Share by Application (2024)
Figure 24. Global Nasal Spray Flu Vaccines Revenue Market Share by Application in 2025
Figure 25. Nasal Spray Flu Vaccines Sales by Company in 2025 (K Doses)
Figure 26. Global Nasal Spray Flu Vaccines Sales Market Share by Company in 2025
Figure 27. Nasal Spray Flu Vaccines Revenue by Company in 2025 ($ millions)
Figure 28. Global Nasal Spray Flu Vaccines Revenue Market Share by Company in 2025
Figure 29. Global Nasal Spray Flu Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Nasal Spray Flu Vaccines Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Nasal Spray Flu Vaccines Sales 2020-2025 (K Doses)
Figure 32. Americas Nasal Spray Flu Vaccines Revenue 2020-2025 ($ millions)
Figure 33. APAC Nasal Spray Flu Vaccines Sales 2020-2025 (K Doses)
Figure 34. APAC Nasal Spray Flu Vaccines Revenue 2020-2025 ($ millions)
Figure 35. Europe Nasal Spray Flu Vaccines Sales 2020-2025 (K Doses)
Figure 36. Europe Nasal Spray Flu Vaccines Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Nasal Spray Flu Vaccines Sales 2020-2025 (K Doses)
Figure 38. Middle East & Africa Nasal Spray Flu Vaccines Revenue 2020-2025 ($ millions)
Figure 39. Americas Nasal Spray Flu Vaccines Sales Market Share by Country in 2025
Figure 40. Americas Nasal Spray Flu Vaccines Revenue Market Share by Country (2020-2025)
Figure 41. Americas Nasal Spray Flu Vaccines Sales Market Share by Type (2020-2025)
Figure 42. Americas Nasal Spray Flu Vaccines Sales Market Share by Application (2020-2025)
Figure 43. United States Nasal Spray Flu Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Nasal Spray Flu Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Nasal Spray Flu Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Nasal Spray Flu Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Nasal Spray Flu Vaccines Sales Market Share by Region in 2025
Figure 48. APAC Nasal Spray Flu Vaccines Revenue Market Share by Region (2020-2025)
Figure 49. APAC Nasal Spray Flu Vaccines Sales Market Share by Type (2020-2025)
Figure 50. APAC Nasal Spray Flu Vaccines Sales Market Share by Application (2020-2025)
Figure 51. China Nasal Spray Flu Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Nasal Spray Flu Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Nasal Spray Flu Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Nasal Spray Flu Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. India Nasal Spray Flu Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Nasal Spray Flu Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Nasal Spray Flu Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Nasal Spray Flu Vaccines Sales Market Share by Country in 2025
Figure 59. Europe Nasal Spray Flu Vaccines Revenue Market Share by Country (2020-2025)
Figure 60. Europe Nasal Spray Flu Vaccines Sales Market Share by Type (2020-2025)
Figure 61. Europe Nasal Spray Flu Vaccines Sales Market Share by Application (2020-2025)
Figure 62. Germany Nasal Spray Flu Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. France Nasal Spray Flu Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Nasal Spray Flu Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Nasal Spray Flu Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Nasal Spray Flu Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Nasal Spray Flu Vaccines Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Nasal Spray Flu Vaccines Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Nasal Spray Flu Vaccines Sales Market Share by Application (2020-2025)
Figure 70. Egypt Nasal Spray Flu Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Nasal Spray Flu Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Nasal Spray Flu Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Nasal Spray Flu Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Nasal Spray Flu Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Nasal Spray Flu Vaccines in 2025
Figure 76. Manufacturing Process Analysis of Nasal Spray Flu Vaccines
Figure 77. Industry Chain Structure of Nasal Spray Flu Vaccines
Figure 78. Channels of Distribution
Figure 79. Global Nasal Spray Flu Vaccines Sales Market Forecast by Region (2026-2031)
Figure 80. Global Nasal Spray Flu Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Nasal Spray Flu Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Nasal Spray Flu Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Nasal Spray Flu Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Nasal Spray Flu Vaccines Revenue Market Share Forecast by Application (2026-2031)